Literature DB >> 9242200

Variability of endocrinological dysfunction in 55 patients with X-linked adrenoleucodystrophy: clinical, laboratory and genetic findings.

G C Korenke1, C Roth, E Krasemann, M Hüfner, D H Hunneman, F Hanefeld.   

Abstract

X-linked adrenoleucodystrophy (ALD) has been shown to be one of the most frequent causes of Addison's disease in men. It is characterized by an impaired peroxisomal beta-oxidation of very long chain fatty acids and is associated with mutations of the ALD gene resulting in a defective peroxisomal membrane transport protein. There is a striking variability of endocrinological and neurological symptoms in patients with ALD, with no clearly evident correlation between mutations of the ALD gene and the different neurological phenotypes. No data on endocrinological symptoms and the ALD genotype have been published so far. We report endocrinological, clinical, laboratory and molecular genetic data from 55 patients with ALD from 34 families. Endocrinological symptoms of adrenal insufficiency were observed in 33 patients, 20 of whom showed additional neurological symptoms of cerebral ALD or adrenomyeloneuropathy. Isolated neurological symptoms were seen in 12 patients; in nine patients there were neither endocrinological nor neurological symptoms. Mutations of the ALD gene (n = 28) were detected in 50 patients (including nine sets of brothers) from 32 families. No correlation was found between the ALD gene mutation and endocrinological dysfunction. However, we found that all sets of brothers were concordant for the endocrinological phenotype (cortisol synthesis was reduced in two sets and normal in seven sets), whereas four sets showed a discordant neurological phenotype. As yet unknown hereditary factors other than mutations within the ALD gene may interfere with the endocrinological phenotype more strongly than with the neurological phenotype of ALD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242200     DOI: 10.1530/eje.0.1370040

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

1.  Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".

Authors:  B M van Geel; J Assies; E B Haverkort; J H Koelman; B Verbeeten; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes.

Authors:  Lynda E Polgreen; Saydi Chahla; Weston Miller; Steven Rothman; Jakub Tolar; Teresa Kivisto; David Nascene; Paul J Orchard; Anna Petryk
Journal:  Eur J Pediatr       Date:  2011-01-29       Impact factor: 3.183

3.  Adrenal steroids in adrenomyeloneuropathy. Dehydroepiandrosterone sulfate, androstenedione and 17alpha-hydroxyprogesterone.

Authors:  Maria Wichers-Rother; Andreas Grigull; Piotr Sokolowski; Birgit Stoffel-Wagner; Wolfgang Köhler
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

4.  No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophy.

Authors:  A Petryk; L E Polgreen; S Chahla; W Miller; P J Orchard
Journal:  Bone Marrow Transplant       Date:  2012-03-05       Impact factor: 5.483

5.  Clinical Profile of Addison's Disease in a Tertiary Care Institute, Southern India - The Changing Landscape.

Authors:  Subbiah Sridhar; Karthik Balachandran; Roshan Nazirudeen; Vasanthiy Natarajan; Jayaraman Sangumani
Journal:  Indian J Endocrinol Metab       Date:  2022-04-27

6.  Clinical profile of adrenoleukodysrophy.

Authors:  Shrikrishna V Acharya; Raju A Gopal; Tushar R Bandgar; Shashank R Joshi; Padma S Menon; Nalini S Shah
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

7.  Clinical, biochemical, neuroimaging and molecular findings of X-linked Adrenoleukodystrophy patients in South China.

Authors:  Min-yan Jiang; Yan-na Cai; Cui-li Liang; Min-zhi Peng; Hui-ying Sheng; Li-ping Fan; Rui-zhu Lin; Hua Jiang; Yonglan Huang; Li Liu
Journal:  Metab Brain Dis       Date:  2015-08-12       Impact factor: 3.584

8.  Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation.

Authors:  Alex R Kemper; Jeffrey Brosco; Anne Marie Comeau; Nancy S Green; Scott D Grosse; Elizabeth Jones; Jennifer M Kwon; Wendy K K Lam; Jelili Ojodu; Lisa A Prosser; Susan Tanksley
Journal:  Genet Med       Date:  2016-06-23       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.